ConductScience.org, home

Paper9736573

Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration.

Thalhammer F and 8 others. Antimicrob Agents Chemother, 1998. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration. Papers, record 9736573. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9736573

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Single-dose pharmacokinetics of meropenem during continuous venovenous hemofiltration.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1998
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
3.52
iCite
Revised in PubMed
2023-11-05
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thalhammer FF
2Schenk PP
3Burgmann HH
4El Menyawi II
5Hollenstein UMU M
6Rosenkranz ARA R
7Sunder-Plassmann GG
8Breyer SS
9Ratheiser KK

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HemofiltrationMajor topic
ThienamycinsMajor topic
Aged
Female
Humans
Male
Meropenem
Middle Aged

Source PubMed

Download CSV of topics

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17803882Meropenem: a new carbapenem antimicrobial.Ann Pharmacother1994https://conductscience.org/library/papers/7803882PubMed
23163038Pump assisted continuous venovenous hemofiltration for treating acute uremia.Kidney Int Suppl1988https://conductscience.org/library/papers/3163038PubMed
31482127Continuous infusion of beta-lactam antibiotics.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1482127PubMed
41802557Drug removal during continuous hemofiltration or hemodialysis.Contrib Nephrol1991https://conductscience.org/library/papers/1802557PubMed
58647616Basic mechanisms and definitions for continuous renal replacement therapies.Int J Artif Organs1996https://conductscience.org/library/papers/8647616PubMed
67593908Pharmacokinetics of continuous renal replacement therapy.Intensive Care Med1995https://conductscience.org/library/papers/7593908PubMed
79420033Pharmacokinetics of imipenem-cilastatin in critically ill patients undergoing continuous venovenous hemofiltration.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9420033PubMed
89200809Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes.Wien Klin Wochenschr1997https://conductscience.org/library/papers/9200809PubMed
92512140In vitro antibacterial activity and beta-lactamase stability of the new carbapenem SM-7338.Eur J Clin Microbiol Infect Dis1989https://conductscience.org/library/papers/2512140PubMed
108452352Pharmacokinetics of meropenem in patients with various degrees of renal function, including patients with end-stage renal disease.Antimicrob Agents Chemother1993https://conductscience.org/library/papers/8452352PubMed
111510437Removal of vancomycin by high-flux hemodialysis membranes.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1510437PubMed
128626257Antimicrobial prescribing in patients on haemofiltration.J Antimicrob Chemother1995https://conductscience.org/library/papers/8626257PubMed
138988066Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes.Clin Pharmacol Ther1996https://conductscience.org/library/papers/8988066PubMed
142770120Markedly increased clearance of vancomycin during hemodialysis using polysulfone dialyzers.Kidney Int1989https://conductscience.org/library/papers/2770120PubMed
151510451Pharmacokinetics of meropenem in subjects with various degrees of renal impairment.Antimicrob Agents Chemother1992https://conductscience.org/library/papers/1510451PubMed
168430678Comparison of imipenem pharmacokinetics in patients with acute or chronic renal failure treated with continuous hemofiltration.Am J Kidney Dis1993https://conductscience.org/library/papers/8430678PubMed
177652504Laboratory data which differentiate meropenem and imipenem.Scand J Infect Dis Suppl1995https://conductscience.org/library/papers/7652504PubMed
189174173Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.Antimicrob Agents Chemother1997https://conductscience.org/library/papers/9174173PubMed
191607000Pharmacokinetics of meropenem in subjects with renal insufficiency.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1607000PubMed
202055812Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem.J Antimicrob Chemother1991https://conductscience.org/library/papers/2055812PubMed

See all 24 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
42730518Integrating CRRT as a Virtual Organ Into Physiologically Based Pharmacokinetic Modeling to Optimize Antimicrobial Dosing in Septic Patients.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/42730518PubMed
41792368Development and validation of a machine learning model for individualised meropenem dosing in CRRT patients.Sci Rep2026https://conductscience.org/library/papers/41792368PubMed
40143863Phage-antibiotic combinations against Klebsiella pneumoniae: impact of methodological approaches on effect evaluation.Front Microbiol2025https://conductscience.org/library/papers/40143863PubMed
37630297Analytical and Clinical Validation of Assays for Volumetric Absorptive Microsampling (VAMS) of Drugs in Different Blood Matrices: A Literature Review.Molecules2023https://conductscience.org/library/papers/37630297PubMed
36005753Population Pharmacokinetic Meta-Analysis and Dosing Recommendation for Meropenem in Critically Ill Patients Receiving Continuous Renal Replacement Therapy.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/36005753PubMed
31355341Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii.Sci Adv2019https://conductscience.org/library/papers/31355341PubMed
30118674Beta-lactam carryover in arterial and central venous catheters is negligible.Clin Chim Acta2018https://conductscience.org/library/papers/30118674PubMed
30094712A Robust Statistical Approach to Analyse Population Pharmacokinetic Data in Critically Ill Patients Receiving Renal Replacement Therapy.Clin Pharmacokinet2019https://conductscience.org/library/papers/30094712PubMed
30082292Ex Vivo Characterization of Effects of Renal Replacement Therapy Modalities and Settings on Pharmacokinetics of Meropenem and Vaborbactam.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/30082292PubMed
26997934Pharmacokinetics of Continuous Infusion Meropenem With Concurrent Extracorporeal Life Support and Continuous Renal Replacement Therapy: A Case Report.J Pediatr Pharmacol Ther2016https://conductscience.org/library/papers/26997934PubMed
26711775Doripenem Treatment during Continuous Renal Replacement Therapy.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26711775PubMed
26124172Meropenem population pharmacokinetics in critically ill patients with septic shock and continuous renal replacement therapy: influence of residual diuresis on dose requirements.Antimicrob Agents Chemother2015https://conductscience.org/library/papers/26124172PubMed
25881576A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics.Crit Care2015https://conductscience.org/library/papers/25881576PubMed
25042938Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.Crit Care2014https://conductscience.org/library/papers/25042938PubMed
24643839[Pharmacokinetic and pharmacodynamic aspects in antibiotic treatment].Med Klin Intensivmed Notfmed2014https://conductscience.org/library/papers/24643839PubMed
24419341Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24419341PubMed
22839761Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review.Ann Intensive Care2012https://conductscience.org/library/papers/22839761PubMed
21649882Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy.Crit Care2011https://conductscience.org/library/papers/21649882PubMed
20479205Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration.Antimicrob Agents Chemother2010https://conductscience.org/library/papers/20479205PubMed
18307371Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy.Clin Pharmacokinet2008https://conductscience.org/library/papers/18307371PubMed

See all 27 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9736573

GET https://conductscience.org/api/papers/v1/9736573/references?page=2